Outcome of the Board Meeting held on 26th August, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Evoq Remedies Limited's Board of Directors, at a meeting held on 26th August 2025, approved the recommendation to appoint M/s. H Thakkar & Co. LLP, Chartered Accountants (FRN: W100891), as the new Statutory Auditor of the company. The appointment is proposed for a 5-year term covering FY 2025-26 through FY 2029-30, subject to shareholder approval. The firm is based in Mumbai and specializes in company audits, taxation, and corporate advisory. The Board also approved the notice for the 15th Annual General Meeting (AGM), scheduled for 17th September 2025 via video conferencing.
This is a routine corporate governance update. The change in statutory auditor aligns with the end of the previous auditor's term, and the new auditor's 5-year appointment provides continuity. Neutral to mildly positive signal for shareholders, as it reflects compliance with listing regulations ahead of the AGM.